GlassScriptPhysician profile
Donald C Tomasello
NPI 1689662629
$12,215.72
in general payments reported to CMS, 2019-2025
12 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.86 · 2020: $146 · 2021: $282 · 2022: $63.16 · 2023: $9,638 · 2024: $1,593 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,500 · Travel and Lodging: $1,855 · Food and Beverage: $1,324 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,500.00 |
| Travel and Lodging | $1,854.73 |
| Food and Beverage | $1,324.33 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,986.85 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Ethicon US, LLC | $326.84 | 2023-2025 | Enseal, Enseal X1, Megadyne |
| Smith+Nephew, INC. | $282.04 | 2021 | |
| Phathom Pharmaceuticals, INC. | $217.91 | 2024-2025 | Voquezna |
| Integra Lifesciences Corporation | $145.86 | 2020 | |
| Medtronic, INC. | $120.85 | 2022-2025 | Signia, Parietex, Progrip |
| Baxter Healthcare | $29.43 | 2023 | Perclot |
| Merck Sharp & Dohme LLC | $27.37 | 2019-2022 | |
| Covidien LP | $23.74 | 2019 | |
| Kci USA, INC. | $21.88 | 2023 | Activ.A.C., V.A.C. Dermatac, Promogran Prisma |
| Daiichi Sankyo INC. | $16.55 | 2022 | |
| Olympus America INC. | $16.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Tomasello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.